Crinetics Pharmaceuticals, Inc. — Form D

Crinetics Pharmaceuticals, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-11-16. The offering totals $40.0M, of which $18.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (30)

Showing 25 of 30 people.

NameRoleLocation
Mason Scott FreemanDirectorSan Diego, CA
Steve Scott KaldorDirectorSan Diego, CA
Mahendra Scott ShahDirectorSan Diego, CA
Richard Scott StruthersDirectorSan Diego, CA
Wendell Scott WierengaDirectorSan Diego, CA
Stephen F BetzExecutive OfficerSan Diego, CA
Richard Scott StruthersExecutive OfficerSan Diego, CA
YunFei F ZhuExecutive OfficerSan Diego, CA
JAMES VIVALDI HASSARDExecutive OfficerSAN DIEGO, CA
STEPHEN VIVALDI BETZExecutive OfficerSAN DIEGO, CA
ROGERIO VIVALDI COELHO, M.D.DirectorSAN DIEGO, CA
WESTON SCOTT NICHOLS, PhDDirectorSAN DIEGO, CA
MARC SCOTT WILSONExecutive OfficerSAN DIEGO, CA
CAMILLE SCOTT BEDROSIAN, M.D.DirectorSAN DIEGO, CA
MATTHEW SCOTT FUSTDirectorSAN DIEGO, CA
RICHARD SCOTT STRUTHERS, PhDDirectorSAN DIEGO, CA
RICHARD SCOTT STRUTHERS, PhDExecutive OfficerSAN DIEGO, CA
JEFF VIVALDI KNIGHTExecutive OfficerSAN DIEGO, CA
WENDELL SCOTT WIERENGA, PhDDirectorSAN DIEGO, CA
DANA VIVALDI PIZZUTIExecutive OfficerSAN DIEGO, CA
CAREN SCOTT DEARDORFDirectorSAN DIEGO, CA
STEPHANIE SCOTT OKEYDirectorSAN DIEGO, CA
Matthew K FustDirectorMenlo Park, CA
Mason Scott Freeman, M.D.DirectorSan Diego, CA
Wendell Scott Wierenga, Ph.DDirectorSan Diego, CA

Other filings by this issuer (2)

FiledFormOfferingSold
2024-03-11D$350.0M$350.0M
2018-02-23D$65.0M$60.0M

More